Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma

This study has been completed.

Study NCT00003993 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: March 13, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2008 (Final data collection date for primary outcome measure)